Skip to main content

Advertisement

Springer Nature Link
Log in

Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

Gene polymorphisms of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6) may influence the risk of Graves' disease, but the results of so far published studies remain inconclusive. Therefore, the authors conducted this meta-analysis to assess relationships between TNF-α/IL-1/IL-6 polymorphisms and the risk of Graves' disease by pooling the findings of all relevant studies.

Methods

A comprehensive literature searching of Pubmed, Embase, Web of Science and CNKI was conducted by the authors, and twenty-eight studies were found to be eligible for pooled analyses.

Results

The pooled meta-analyses results showed that genotypic frequencies of TNF-α rs1800629, IL-1A rs1800587, IL-6 rs1800795 and IL-6 rs1800796 polymorphisms among patients with Graves' disease and control subjects differed significantly. Moreover, we found that genotypic frequencies of TNF-α rs1800629 and IL-6 rs1800795 polymorphisms among patients with Graves' disease and control subjects in Caucasians differed significantly, and genotypic frequencies of IL-1A rs1800587, IL-1B rs16944, IL-6 rs1800795 and IL-6 rs1800796 polymorphisms among patients with Graves' disease and control subjects in Asians also differed significantly. Nevertheless, we did not detect such genotypic frequencies differences for TNF-α rs361525 and IL-1B rs1143627 polymorphisms.

Conclusions

This meta-analysis suggests that TNF-α rs1800629, IL-1A rs1800587, IL-6 rs1800795 and IL-6 rs1800796 polymorphisms may influence the risk of Graves' disease in overall population. Moreover, TNF-α rs1800629 and IL-6 rs1800795 polymorphisms may influence the risk of Graves' disease in Caucasians, while IL-1A rs1800587, IL-1B rs16944, IL-6 rs1800795 and IL-6 rs1800796 polymorphisms may influence the risk of Graves' disease in Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Not applicable.

References

  1. De Leo S, Lee SY, Braverman LE (2016) Hyperthyroidism. Lancet 388:906–918

    Article  Google Scholar 

  2. Taylor PN, Albrecht D, Scholz A et al (2018) Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14:301–316

    Article  Google Scholar 

  3. Ramos-Leví AM, Marazuela M (2016) Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr 63:421–429

    Article  Google Scholar 

  4. Huang Y, Fang S, Li D, Zhou H, Li B, Fan X (2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye (Lond) 33:176–182

    Article  CAS  Google Scholar 

  5. Vitales-Noyola M, Ramos-Levi AM, Martínez-Hernández R et al (2017) Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine 57:409–417

    Article  CAS  Google Scholar 

  6. Lv LF, Jia HY, Zhang HF, Hu YX (2017) Expression level and clinical significance of IL-2, IL-6 and TGF-β in elderly patients with goiter and hyperthyroidism. Eur Rev Med Pharmacol Sci 21:4680–4686

    PubMed  Google Scholar 

  7. Akahane M, Watanabe M, Inoue N et al (2016) Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases. Autoimmunity 49:312–319

    Article  CAS  Google Scholar 

  8. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269

    Article  Google Scholar 

  9. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  Google Scholar 

  10. Anvari M, Khalilzadeh O, Esteghamati A et al (2010) Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ. Endocrine 37:344–348

    Article  CAS  Google Scholar 

  11. Bednarczuk T, Hiromatsu Y, Seki N et al (2014) Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum Immunol 65:632–639

    Article  Google Scholar 

  12. Gu LQ, Zhu W, Pan CM et al (2010) Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease. Clin Biochem 43:223–227

    Article  CAS  Google Scholar 

  13. Kamizono S, Hiromatsu Y, Seki N et al (2000) A polymorphism of the 5' flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 52:759–764

    Article  CAS  Google Scholar 

  14. Simmonds MJ, Heward JM, Howson JM et al (2004) A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun 5:267–273

    Article  CAS  Google Scholar 

  15. Yang HW, Wang YX, Bao J et al (2017) Correlation of HLA-DQ and TNF-α gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathy. Biosci Rep 37:BSR20160440

    Article  CAS  Google Scholar 

  16. Chen RH, Chen WC, Wang TY, Tsai CH, Tsai FJ (2005) Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease. Int J Immunogenet 32:343–347

    Article  CAS  Google Scholar 

  17. Chen JD (2010) Associations between inflammatory cytokine polymorphisms and Graves' disease. Dissertation, Hebei University of Chinese Medicine.

  18. Durães C, Moreira CS, Alvelos I et al (2014) Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease. PLoS ONE 9:e105492

    Article  Google Scholar 

  19. Jiang WY (2004) Associations between TNFA polymorphisms and Graves' disease. Dissertation, Shandong University.

  20. Jurecka-Lubieniecka B, Ploski R, Kula D et al (2013) Association between age at diagnosis of Graves' disease and variants in genes involved in immune response. PLoS ONE 8:e59349

    Article  CAS  Google Scholar 

  21. Kutluturk F, Yarman S, Sarvan FO, Kekik C (2013) Association of cytokine gene polymorphisms (IL6, IL10, TNF-α, TGF-β and IFN-γ) and Graves' disease in Turkish population. Endocr Metab Immune Disord Drug Targets 13:163–167

    Article  CAS  Google Scholar 

  22. Shiau MY, Huang CN, Yang TP et al (2007) Cytokine promoter polymorphisms in Taiwanese patients with Graves' disease. Clin Biochem 40:213–217

    Article  CAS  Google Scholar 

  23. Gong Y (2003) Associations between interleukin polymorphisms and Graves' disease. Dissertation, Shandong University.

  24. Kammoun-Krichen M, Bougacha-Elleuch N, Makni K et al (2007) Association analysis of interleukin gene polymorphisms in autoimmune thyroid diseases in the Tunisian population. Eur Cytokine Netw 18:196–200

    CAS  PubMed  Google Scholar 

  25. Khalilzadeh O, Anvari M, Momen-Heravi F et al (2010) Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease. Clin Exp Med 10:123–128

    Article  CAS  Google Scholar 

  26. Liu N, Li X, Liu C et al (2010) The association of interleukin-1alpha and interleukin-1beta polymorphisms with the risk of Graves' disease in a case-control study and meta-analysis. Hum Immunol 71:397–401

    Article  CAS  Google Scholar 

  27. Hayashi F, Watanabe M, Nanba T et al (2009) Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells. Clin Exp Immunol 158:281–286

    Article  CAS  Google Scholar 

  28. Khalilzadeh O, Anvari M, Esteghamati A et al (2009) The interleukin-1 family gene polymorphisms and Graves' disease. Ann Endocrinol (Paris) 71:281–285

    Article  Google Scholar 

  29. Lacka K, Paradowska A, Gasinska T et al (2009) Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population. Curr Eye Res 34:215–220

    Article  CAS  Google Scholar 

  30. Reichmann I, Schulte KM, Roeher HD (2004) No association of IL-1beta C + 3954 T polymorphism and thyroid disease. Exp Clin Endocrinol Diabetes 112:440–443

    Article  CAS  Google Scholar 

  31. Shehjar F, Afroze D, Misgar RA, Malik SA, Laway BA (2018) Association of polymorphic variants of IL-1β and IL-1RN genes in the development of Graves' disease in Kashmiri population (North India). Hum Immunol 79:228–232

    Article  CAS  Google Scholar 

  32. Zaaber I, Mestiri S, Hammedi H et al (2016) Association of interleukin-1B and Interleukin-4 gene variants with autoimmune thyroid diseases in tunisian population. Immunol Invest 45:284–297

    Article  CAS  Google Scholar 

  33. Liu YH, Chen RH, Wu HH et al (2010) Association of interleukin-1beta (IL1B) polymorphisms with Graves' ophthalmopathy in Taiwan Chinese patients. Invest Ophthalmol Vis Sci 51:6238–6246

    Article  Google Scholar 

  34. Anvari M, Khalilzadeh O, Esteghamati A et al (2010) Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye (Lond) 24:1058–1063

    Article  CAS  Google Scholar 

  35. Zhu W, Liu N, Zhao Y et al (2010) Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease. J Endocrinol Invest 33:751–755

    Article  CAS  Google Scholar 

  36. Inoue N, Watanabe M, Morita M et al (2011) Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol 163:318–323

    Article  CAS  Google Scholar 

  37. Mestiri S, Zaaber I, Inoubli O et al (2020) Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population. Int J Immunogenet. https://doi.org/10.1111/iji.12472

    Article  PubMed  Google Scholar 

  38. Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20:43–59

    Article  CAS  Google Scholar 

  39. Ferrari SM, Ruffilli I, Elia G et al (2019) Chemokines in hyperthyroidism. J Clin Transl Endocrinol 16:100196

    PubMed  PubMed Central  Google Scholar 

  40. Mandić JJ, Kozmar A, Kusačić-Kuna S et al (2018) The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis. Graefes Arch Clin Exp Ophthalmol 256:845–852

    Article  Google Scholar 

  41. Li L, Ding X, Wang X et al (2018) Polymorphisms of IKZF3 gene and autoimmune thyroid diseases: associated with Graves' disease but not with Hashimoto's thyroiditis. Cell Physiol Biochem 45:1787–1796

    Article  CAS  Google Scholar 

  42. Yao Q, Li J, An X et al (2017) Association between C1q gene polymorphisms and autoimmune thyroid diseases. Arch Endocrinol Metab 61:337–342

    Article  Google Scholar 

  43. Cai T, Li J, An X et al (2017) Polymorphisms in MIR499A and MIR125A gene are associated with autoimmune thyroid diseases. Mol Cell Endocrinol 440:106–115

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Huaian Hospital of Huaian District, Huaian, 223200, China

    P. Zhu, X. Wu & J. Zhou

  2. Department of Clinical Medicine, Yangzhou University Medical College, Yangzhou, 225009, China

    K. Wu

  3. Department of Endocrinology, Xiamen Haicang Hospital, Xiamen, 361026, China

    Y. Lu

Authors
  1. P. Zhu
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. X. Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. J. Zhou
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. K. Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Y. Lu
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

PZ and YL designed this meta-analysis. PZ, XW and JZ searched literatures. JZ and KW analyzed data. PZ and YL wrote the manuscript. All authors approved the final manuscript as submitted.

Corresponding author

Correspondence to Y. Lu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 993 kb)

Supplementary file2 (DOCX 411 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, P., Wu, X., Zhou, J. et al. Gene polymorphisms of pro-inflammatory cytokines may affect the risk of Graves' disease: a meta-analysis. J Endocrinol Invest 44, 311–319 (2021). https://doi.org/10.1007/s40618-020-01300-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01300-x

Keywords